Dr Susana Banerjee is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit at The Royal Marsden NHS Foundation Trust and a Team Leader in Gynaecological Cancers (Systemic Therapy and Clinical Trials). Dr Banerjee specialises in ovarian cancer and advanced endometrial and cervical cancers. Dr Banerjee graduated with a 1st class degree from St John's College, University of Cambridge and completed her medical training at Royal Free Medical School, where she was a University of London Gold Medal Finalist. Dr Banerjee was awarded an Avon Breast Cancer Crusade Clinical Fellowship for laboratory research and gained a PhD from The Institute of Cancer Research, London. In 2007, she was awarded the San Antonio Breast Cancer Symposium Novartis Oncology Basic Science Award for her research. Other prizes include the Association of Cancer Physicians McElwain Prize, Sir Antony Driver Prize (ICR) and Pfizer British Oncology Association Young Investigator Award (highly commended). She completed specialist medical oncology training at The Royal Marsden and was appointed a Consultant in 2011. In June 2015, she joined the ICR as Associate Honorary Faculty. Dr Banerjee serves on national and international specialist groups, including the National Cancer Research Institute Gynaecological Cancers Clinical Studies Group, European Organization for Research and Treatment of Cancer Executive Steering Committee for Gynaecological Cancers and the European Society of Medical Oncology (ESMO) Gynaecological Cancers Faculty. In the past, she was a member of the ESMO Young Oncologists' Committee and the European Society of Gynaecological Oncology Faculty. Dr Banerjee is currently a member of the ESMO Women for Oncology Committee and recently was selected to join the ESMO Executive Board. She is actively involved in clinical trials and translational research. Her research interests include individualisation of patient treatment and targeted therapies in gynaecological cancers. Dr Banerjee has active collaborations with other ICR teams – Dr Chris Lord (Gene Function Team), Dr Rachael Natrajan (Functional Genomics), Dr Yinyin Yuan (Computational Pathology and Integrative Genomics Team) and Dr Udai Banerji (Clinical Pharmacology and Trials). She supervises MD(Res) and PhD students. In addition to principal investigator roles, Dr Banerjee is UK Chief Investigator for a number of national and international clinical trials.

 Team Our mission is to improve the outcomes of women with gynaecological cancers. We contribute to the achievement of this goal by collaborating nationally and internationally on clinical studies. We work closely with laboratory scientists to help take forward pre-clinical findings through to patients in the clinic. The interaction between the clinic and lab is key to understanding mechanisms of resistance and identifying patients most likely to benefit from therapies. We also aim to address important clinical and biological questions in retrospective analyses including patients treated at The Royal Marsden NHS Foundation Trust. This can be very useful to enhance our understanding of the behaviour of rare gynaecological cancers. In addition to developing new systemic therapy options, our team is focusing on research to help improve the patient experience while undergoing cancer treatment.